Sportelli, Leonardo http://orcid.org/0000-0002-3028-3262
Eisenberg, Daniel P. http://orcid.org/0000-0003-4306-9342
Passiatore, Roberta
D’Ambrosio, Enrico http://orcid.org/0000-0001-9774-3860
Antonucci, Linda A.
Bettina, Jasmine S.
Chen, Qiang
Goldman, Aaron L.
Gregory, Michael D. http://orcid.org/0000-0003-3749-8343
Griffiths, Kira
Hyde, Thomas M. http://orcid.org/0000-0002-8746-3037
Kleinman, Joel E. http://orcid.org/0000-0002-4210-6052
Pardiñas, Antonio F. http://orcid.org/0000-0001-6845-7590
Parihar, Madhur http://orcid.org/0000-0001-7747-0922
Popolizio, Teresa
Rampino, Antonio
Shin, Joo Heon http://orcid.org/0000-0002-5563-8605
Veronese, Mattia http://orcid.org/0000-0003-3562-0683
Ulrich, William S.
Zink, Caroline F.
Bertolino, Alessandro
Howes, Oliver D. http://orcid.org/0000-0002-2928-1972
Berman, Karen F.
Weinberger, Daniel R. http://orcid.org/0000-0003-2409-2969
Pergola, Giulio http://orcid.org/0000-0002-9193-1841
Article History
Received: 4 September 2023
Accepted: 22 March 2024
First Online: 30 April 2024
Competing interests
: E.D. and G.P. received lecture fees from Lundbeck. A.R. received travel fees from Lundbeck. A.B. received consulting fees from Biogen and lecture fees from Otsuka, Janssen, and Lundbeck. O.D.H. has received investigator-initiated research funding from and/or participated in advisory/speaker meetings organized by Angelini, Autifony, Biogen, Boehringer Ingelheim, Eli Lilly, Heptares, Global Medical Education, Invicro, Janssen, Lundbeck, Neurocrine, Otsuka, Sunovion, Recordati, Roche and Viatris/Mylan and was a part-time employee of H Lundbeck A/s. O.D.H. and M.V. have a patent for the use of dopaminergic imaging. D.R.W. serves on the Scientific Advisory Boards of Sage Therapeutics and Pasithea Therapeutics. The remaining authors declare no competing interests.